Showing results (381-390 of 517) with videos related to
Sort By:
Pageof 52
The Prostate|January 5, 2022
Pilot study of the diagnostic utility of 89 Zr-df-IAB2M and 68 Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancerPanagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, et al.Cancer Chemotherapy and Pharmacology|August 8, 2013
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)Hielke J Meulenbeld, Johann S de Bono, Scott T Tagawa, et al.The Prostate|January 19, 2021
Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancerPanagiotis J Vlachostergios, Muhammad Junaid Niaz, Myrto Skafida, et al.Endoscopy|September 19, 2006
Endoscopic in vivo evaluation of tissue atypia in the esophagus using a newly designed integrated endocytoscope: a pilot trialH Inoue, K Sasajima, M Kaga, et al.Frontiers in Oncology|March 8, 2021
Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate CancerPanagiotis J Vlachostergios, Muhammad Junaid Niaz, Michael Sun, et al.FEMS Microbiology Letters|September 1, 1995
Isolation of promoters from Brevibacterium flavum strain MJ233C and comparison of their gene expression levels in B. flavum and Escherichia coliT J Zupancic, J D Kittle, B D Baker, et al.Cancer|April 24, 2019
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177 Lu-J591) for metastatic castration-resistant prostate cancerScott T Tagawa, Shankar Vallabhajosula, Paul J Christos, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 7, 2018
Viscoelastic anomaly accompanying anti-crossing behaviour in liquid As2Se3M Inui, A Q R Baron, Y Kajihara, et al.European Journal of Radiology|September 3, 2024
PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancerDivya Yadav, Silvina P Dutruel, Elisabeth O'Dwyer, et al.The Oncologist|January 31, 2020
Pilot Study of Hyperfractionated Dosing of Lutetium-177-Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 (177 Lu-J591) for Metastatic Castration-Resistant Prostate CancerMuhammad Junaid Niaz, Jaspreet S Batra, Ryan D Walsh, et al.Pageof 52